Health Board
 

The safety implications of plasma pool sizes in the manufacture of fractionated blood products.

Search Health Board More search options

Medicine: Medical Specialties: Hematology: Blood Products: Safety: Testimony-Kathryn C. Zoon, PH.D. (JULY 31, 1997)  Previous
 

Testimony-Kathryn C. Zoon, PH.D. (JULY 31, 1997)


The safety implications of plasma pool sizes in the manufacture of fractionated blood products.


http://www.fda.gov/ola/plasma.htm.


Free Classified Ads
 
HOMENEW LINKSCOOL LINKSNEWSLETTERRANDOM LINKSUBMIT A SITESEARCH

Copyright © 1997-2008 HealthBoard.com